Santarus Drug Patent Portfolio
Santarus owns 2 orange book drugs protected by 4 US patents Given below is the list of Santarus's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6489346 | Substituted benzimidazole dosage forms and method of using same | 16 Jul, 2016 | Expired |
| US6645988 | Substituted benzimidazole dosage forms and method of using same | 16 Jul, 2016 | Expired |
| US6699885 | Substituted benzimidazole dosage forms and methods of using same | 16 Jul, 2016 | Expired |
| US7399772 | Substituted benzimidazole dosage forms and method of using same | 16 Jul, 2016 | Expired |
Latest Legal Activities on Santarus's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Santarus.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 17 Aug, 2020 | US7399772 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 02 Mar, 2020 | US7399772 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Jul, 2008 | US7399772 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 15 Jul, 2008 | US7399772 (Litigated) |
|
Issue Notification Mailed
Critical
| 25 Jun, 2008 | US7399772 (Litigated) |
| Dispatch to FDC | 16 Jun, 2008 | US7399772 (Litigated) |
|
Application Is Considered Ready for Issue
Critical
| 04 Jun, 2008 | US7399772 (Litigated) |
|
Issue Fee Payment Received
Critical
| 03 Jun, 2008 | US7399772 (Litigated) |
|
Issue Fee Payment Verified
Critical
| 03 Jun, 2008 | US7399772 (Litigated) |
| Mail Miscellaneous Communication to Applicant | 03 Jun, 2008 | US7399772 (Litigated) |
| Printer Rush- No mailing | 19 May, 2008 | US7399772 (Litigated) |
| Miscellaneous Communication to Applicant - No Action Count | 12 May, 2008 | US7399772 (Litigated) |
|
Pubs Case Remand to TC
Critical
| 06 May, 2008 | US7399772 (Litigated) |
|
Information Disclosure Statement considered
Critical
| 02 May, 2008 | US7399772 (Litigated) |
|
Information Disclosure Statement (IDS) Filed
Critical
| 02 May, 2008 | US7399772 (Litigated) |
Santarus's Family Patents
Santarus Drug List
Given below is the complete list of Santarus's drugs and the patents protecting them.
1. Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate
Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6489346 | Substituted benzimidazole dosage forms and method of using same |
16 Jul, 2016
(8 years ago)
| Expired |
| US6645988 | Substituted benzimidazole dosage forms and method of using same |
16 Jul, 2016
(8 years ago)
| Expired |
| US6699885 | Substituted benzimidazole dosage forms and methods of using same |
16 Jul, 2016
(8 years ago)
| Expired |
| US7399772 | Substituted benzimidazole dosage forms and method of using same |
16 Jul, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate's drug page
2. Zegerid
Zegerid is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6489346 | Substituted benzimidazole dosage forms and method of using same |
16 Jul, 2016
(8 years ago)
| Expired |
| US6645988 | Substituted benzimidazole dosage forms and method of using same |
16 Jul, 2016
(8 years ago)
| Expired |
| US6699885 | Substituted benzimidazole dosage forms and methods of using same |
16 Jul, 2016
(8 years ago)
| Expired |
| US7399772 | Substituted benzimidazole dosage forms and method of using same |
16 Jul, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zegerid's drug page